Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-5233
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS ; day:14 ; month:2 ; year:2021 ; pages:1-8
Acta diabetologica ; (14.2.2021), 1-8
- Creator
-
Giaccari, Andrea
Bonadonna, R. C.
Buzzetti, R.
Perseghin, G.
Cucinotta, D.
Fanelli, C.
Avogaro, A.
Aimaretti, G.
Larosa, M.
Pagano, V.
Bolli, G. B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00592-021-01675-0
- URN
-
urn:nbn:de:101:1-2021040414583320408396
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Giaccari, Andrea
- Bonadonna, R. C.
- Buzzetti, R.
- Perseghin, G.
- Cucinotta, D.
- Fanelli, C.
- Avogaro, A.
- Aimaretti, G.
- Larosa, M.
- Pagano, V.
- Bolli, G. B.
- SpringerLink (Online service)
Other Objects (12)
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
Effect of intensive glycaemic control on moderate hypoglycaemia and ICU length of stay in severe traumatic brain injury
The consequences of hypoglycaemia
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: a subanalysis of the BRIGHT study
Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)
Effect of Baseline Characteristics on Hypoglycaemia Risk with Insulin Glargine 100 U/mL: Post Hoc Analysis of the BEYOND 7 Study
Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs
Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
Effect of intensive glycaemic control on moderate hypoglycaemia and ICU length of stay in severe traumatic brain injury
The consequences of hypoglycaemia
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: a subanalysis of the BRIGHT study
Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)
Effect of Baseline Characteristics on Hypoglycaemia Risk with Insulin Glargine 100 U/mL: Post Hoc Analysis of the BEYOND 7 Study
Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs
Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
Effect of intensive glycaemic control on moderate hypoglycaemia and ICU length of stay in severe traumatic brain injury
The consequences of hypoglycaemia
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: a subanalysis of the BRIGHT study
Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)
Effect of Baseline Characteristics on Hypoglycaemia Risk with Insulin Glargine 100 U/mL: Post Hoc Analysis of the BEYOND 7 Study
Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs